SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$17.55
Tradestie Score
41
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+66.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$121.47
|
$16.93B | 16.1 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.61
|
$15.70B | 32.6 | 52 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$263.52
|
$12.36B | 20.1 | 47 | Compare |
|
EXEL
Exelixis Inc
|
$56.12
|
$11.09B | 18.3 | 41 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$40.82
|
$10.76B | - | 39 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$143.97
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$65.68
|
$10.53B | 177.1 | 58 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.21
|
$10.49B | - | 50 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$72.44
|
$10.22B | - | 57 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$534.49
|
$10.01B | - | 50 | Compare |
More SMMT Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry